Runda Medical sees significant conversion of convertible bonds to shares
As of September 30, 2025, Shanghai Runda Medical Technology's convertible bonds have seen 315,805,000 yuan converted into company shares, representing 57.4191% of the total issued amount. This conversion resulted in 24,141,745 shares, which accounts for 4.1657% of the company's total shares outstanding prior to these conversions.
During the quarter from June 30, 2025, to September 30, 2025, 150,000 yuan of the convertible bonds were converted, adding 11,560 shares to the company's capital. Following these conversions, the outstanding amount of "Runda Convertible Bonds" not yet converted stands at 234,195,000 yuan, or 42.5809% of the total issued convertible bonds.
The company's total share capital has consequently increased to 603,675,824 shares. The convertible bonds, issued on June 17, 2020, began their conversion period on December 23, 2020, and will continue until June 16, 2026. The initial conversion price of 13.36 yuan per share has been adjusted multiple times, most recently to 12.97 yuan per share effective July 18, 2025.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
News Alerts
Get instant email alerts when Shanghai Runda Medical Technology publishes news
Free account required • Unsubscribe anytime